Literature DB >> 18927238

Interplay and effects of temporal changes in the phosphorylation state of serine-302, -307, and -318 of insulin receptor substrate-1 on insulin action in skeletal muscle cells.

Cora Weigert1, Matthias Kron, Hubert Kalbacher, Ann Kathrin Pohl, Heike Runge, Hans-Ulrich Häring, Erwin Schleicher, Rainer Lehmann.   

Abstract

Transduction of the insulin signal is mediated by multisite Tyr and Ser/Thr phosphorylation of the insulin receptor substrates (IRSs). Previous studies on the function of single-site phosphorylation, particularly phosphorylation of Ser-302, -307, and -318 of IRS-1, showed attenuating as well as enhancing effects on insulin action. In this study we investigated a possible cross talk of these opposedly acting serine residues in insulin-stimulated skeletal muscle cells by monitoring phosphorylation kinetics, and applying loss of function, gain of function, and combination mutants of IRS-1. The phosphorylation at Ser-302 was rapid and transient, followed first by Ser-318 phosphorylation and later by phosphorylation of Ser-307, which remained elevated for 120 min. Mutation of Ser-302 to alanine clearly reduced the subsequent protein kinase C-zeta-mediated Ser-318 phosphorylation. The Ser-307 phosphorylation was independent of Ser-302 and/or Ser-318 phosphorylation status. The functional consequences of these phosphorylation patterns were studied by the expression of IRS-1 mutants. The E302A307E318 mutant simulating the early phosphorylation pattern resulted in a significant increase in Akt and glycogen synthase kinase 3 phosphorylation. Furthermore, glucose uptake was enhanced. Because the down-regulation of the insulin signal was not affected, this phosphorylation pattern seems to be involved in the enhancement but not in the termination of the insulin signal. This enhancing effect was completely absent when Ser-302 was unphosphorylated and Ser-307 was phosphorylated as simulated by the A302E307E318 mutant. Phospho-Ser-318, sequentially phosphorylated at least by protein kinase C-zeta and a mammalian target of rapamycin/raptor-dependent kinase, was part of the positive as well as of the subsequent negative phosphorylation pattern. Thus we conclude that insulin stimulation temporally generates different phosphorylation statuses of the same residues that exert different functions in insulin signaling.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18927238      PMCID: PMC5419409          DOI: 10.1210/me.2008-0102

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  64 in total

Review 1.  Critical nodes in signalling pathways: insights into insulin action.

Authors:  Cullen M Taniguchi; Brice Emanuelli; C Ronald Kahn
Journal:  Nat Rev Mol Cell Biol       Date:  2006-02       Impact factor: 94.444

2.  Quantification of phosphorylation of insulin receptor substrate-1 by HPLC-ESI-MS/MS.

Authors:  Zhengping Yi; Moulun Luo; Lawrence J Mandarino; Sara M Reyna; Christopher A Carroll; Susan T Weintraub
Journal:  J Am Soc Mass Spectrom       Date:  2006-02-28       Impact factor: 3.109

Review 3.  Positive and negative regulation of insulin signaling through IRS-1 phosphorylation.

Authors:  Philippe Gual; Yannick Le Marchand-Brustel; Jean-François Tanti
Journal:  Biochimie       Date:  2005-01       Impact factor: 4.079

4.  Amino acid and insulin signaling via the mTOR/p70 S6 kinase pathway. A negative feedback mechanism leading to insulin resistance in skeletal muscle cells.

Authors:  F Tremblay; A Marette
Journal:  J Biol Chem       Date:  2001-08-09       Impact factor: 5.157

5.  Identification of insulin receptor substrate 1 serine/threonine phosphorylation sites using mass spectrometry analysis: regulatory role of serine 1223.

Authors:  Moulun Luo; Sara Reyna; Lishan Wang; ZhengPing Yi; Christopher Carroll; Lily Q Dong; Paul Langlais; Susan T Weintraub; Lawrence J Mandarino
Journal:  Endocrinology       Date:  2005-07-14       Impact factor: 4.736

6.  Activation of protein kinase C zeta induces serine phosphorylation of VAMP2 in the GLUT4 compartment and increases glucose transport in skeletal muscle.

Authors:  L Braiman; A Alt; T Kuroki; M Ohba; A Bak; T Tennenbaum; S R Sampson
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

7.  MAP kinases and mTOR mediate insulin-induced phosphorylation of insulin receptor substrate-1 on serine residues 307, 612 and 632.

Authors:  P Gual; T Grémeaux; T Gonzalez; Y Le Marchand-Brustel; J-F Tanti
Journal:  Diabetologia       Date:  2003-10-25       Impact factor: 10.122

8.  Phosphorylation of IRS1 at serine 307 and serine 312 in response to insulin in human adipocytes.

Authors:  Anna Danielsson; Fredrik H Nystrom; Peter Strålfors
Journal:  Biochem Biophys Res Commun       Date:  2006-02-23       Impact factor: 3.575

9.  Identification of IRS-1 Ser-1101 as a target of S6K1 in nutrient- and obesity-induced insulin resistance.

Authors:  Frédéric Tremblay; Sophie Brûlé; Sung Hee Um; Yu Li; Kohei Masuda; Michael Roden; Xiao Jian Sun; Michael Krebs; Roberto D Polakiewicz; George Thomas; André Marette
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-20       Impact factor: 11.205

10.  Phosphorylation of human insulin receptor substrate-1 at Serine 629 plays a positive role in insulin signaling.

Authors:  Moulun Luo; Paul Langlais; Zhengping Yi; Natalie Lefort; Elena A De Filippis; Hyonson Hwang; Christine Y Christ-Roberts; Lawrence J Mandarino
Journal:  Endocrinology       Date:  2007-07-19       Impact factor: 4.736

View more
  32 in total

Review 1.  Linking mitochondrial bioenergetics to insulin resistance via redox biology.

Authors:  Kelsey H Fisher-Wellman; P Darrell Neufer
Journal:  Trends Endocrinol Metab       Date:  2012-02-02       Impact factor: 12.015

2.  Chronically increased S6K1 is associated with impaired IRS1 signaling in skeletal muscle of GDM women with impaired glucose tolerance postpartum.

Authors:  Linda A Barbour; Carrie E McCurdy; Teri L Hernandez; Jacob E Friedman
Journal:  J Clin Endocrinol Metab       Date:  2011-02-02       Impact factor: 5.958

3.  Insulin and metabolic stress stimulate multisite serine/threonine phosphorylation of insulin receptor substrate 1 and inhibit tyrosine phosphorylation.

Authors:  Nancy J Hançer; Wei Qiu; Christine Cherella; Yedan Li; Kyle D Copps; Morris F White
Journal:  J Biol Chem       Date:  2014-03-20       Impact factor: 5.157

4.  A cardiac myocyte-restricted Lin28/let-7 regulatory axis promotes hypoxia-mediated apoptosis by inducing the AKT signaling suppressor PIK3IP1.

Authors:  Shaurya Joshi; Jianqin Wei; Nanette H Bishopric
Journal:  Biochim Biophys Acta       Date:  2015-12-02

5.  Induction of α cell-restricted Gc in dedifferentiating β cells contributes to stress-induced β-cell dysfunction.

Authors:  Taiyi Kuo; Manashree Damle; Bryan J González; Dieter Egli; Mitchell A Lazar; Domenico Accili
Journal:  JCI Insight       Date:  2019-05-23

Review 6.  Mechanisms of Insulin Action and Insulin Resistance.

Authors:  Max C Petersen; Gerald I Shulman
Journal:  Physiol Rev       Date:  2018-10-01       Impact factor: 37.312

7.  Attenuated mTOR signaling and enhanced autophagy in adipocytes from obese patients with type 2 diabetes.

Authors:  Anita Ost; Kristoffer Svensson; Iida Ruishalme; Cecilia Brännmark; Niclas Franck; Hans Krook; Per Sandström; Preben Kjolhede; Peter Strålfors
Journal:  Mol Med       Date:  2010-03-26       Impact factor: 6.354

Review 8.  The impact of insulin resistance on the kidney and vasculature.

Authors:  Ferruh Artunc; Erwin Schleicher; Cora Weigert; Andreas Fritsche; Norbert Stefan; Hans-Ulrich Häring
Journal:  Nat Rev Nephrol       Date:  2016-10-17       Impact factor: 28.314

9.  Phosphorylation of serine 1137/1138 of mouse insulin receptor substrate (IRS) 2 regulates cAMP-dependent binding to 14-3-3 proteins and IRS2 protein degradation.

Authors:  Sabine S Neukamm; Jennifer Ott; Sascha Dammeier; Rainer Lehmann; Hans-Ulrich Häring; Erwin Schleicher; Cora Weigert
Journal:  J Biol Chem       Date:  2013-04-24       Impact factor: 5.157

10.  Irs1 serine 307 promotes insulin sensitivity in mice.

Authors:  Kyle D Copps; Nancy J Hancer; Lynn Opare-Ado; Wei Qiu; Cari Walsh; Morris F White
Journal:  Cell Metab       Date:  2010-01       Impact factor: 27.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.